These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 18187444)

  • 21. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal changes in HIV-1-specific T-cell quality associated with viral load dynamic.
    Dembek CJ; Kutscher S; Allgayer S; Russo C; Bauer T; Hoffmann D; Goebel FD; Bogner JR; Erfle V; Protzer U; Cosma A
    J Clin Virol; 2012 Oct; 55(2):114-20. PubMed ID: 22795599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy.
    García F; Vidal C; Plana M; Cruceta A; Gallart MT; Pumarola T; Miro JM; Gatell JM
    Clin Infect Dis; 2000 Feb; 30(2):392-4. PubMed ID: 10671348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects.
    Smith RJ; Wahl LM
    Bull Math Biol; 2004 Sep; 66(5):1259-83. PubMed ID: 15294425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression.
    Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J
    Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A stochastic model for early HIV-1 population dynamics.
    Tuckwell HC; Le Corfec E
    J Theor Biol; 1998 Dec; 195(4):451-63. PubMed ID: 9837702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of HIV-1 phenotype in viral pathogenesis and its relation to viral load and CD4+ T-cell count.
    Kupfer B; Kaiser R; Rockstroh JK; Matz B; Schneweis KE
    J Med Virol; 1998 Nov; 56(3):259-63. PubMed ID: 9783695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of inhibitory and activating natural killer cell receptor expression on T cells in human immunodeficiency virus-infected Chinese.
    Jiang Y; Wu S; Zhou F; Bice T; Zhang Z; Liu J; Ding H; Han X; Shang H
    Microbiol Immunol; 2011 Oct; 55(10):715-25. PubMed ID: 21806677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.
    de Mendoza C; Martín-Carbonero L; Gallego O; Corral A; González-Lahoz J; Soriano V
    J Med Virol; 2005 May; 76(1):1-6. PubMed ID: 15778973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
    Cardiello P; Srasuebkul P; Hassink E; Mahanontharit A; Samor T; Ruxrungtham K; Lange J; Cooper D; Phanuphak P
    HIV Med; 2005 Mar; 6(2):122-8. PubMed ID: 15807718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A delay-differential equation model of HIV infection of CD4(+) T-cells.
    Culshaw RV; Ruan S
    Math Biosci; 2000 May; 165(1):27-39. PubMed ID: 10804258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring how to get at--and eradicate--hidden HIV.
    Cohen J
    Science; 1998 Mar; 279(5358):1854-5. PubMed ID: 9537902
    [No Abstract]   [Full Text] [Related]  

  • 33. Estimating kinetic parameters from HIV primary infection data through the eyes of three different mathematical models.
    Ciupe MS; Bivort BL; Bortz DM; Nelson PW
    Math Biosci; 2006 Mar; 200(1):1-27. PubMed ID: 16469337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal control of the chemotherapy of HIV.
    Kirschner D; Lenhart S; Serbin S
    J Math Biol; 1997 Aug; 35(7):775-92. PubMed ID: 9269736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug Therapy for HIV Infection: Dynamics of Immune System.
    Kamboj D; Sharma MD
    Acta Biotheor; 2019 Jun; 67(2):129-147. PubMed ID: 30515609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards a long-term model construction for the dynamic simulation of HIV infection.
    Hadjiandreou M; Conejeros R; Vassiliadis VS
    Math Biosci Eng; 2007 Jul; 4(3):489-504. PubMed ID: 17658937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mathematical analysis of delay differential equation models of HIV-1 infection.
    Nelson PW; Perelson AS
    Math Biosci; 2002; 179(1):73-94. PubMed ID: 12047922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rate of killing of HIV-infected T cells and disease progression.
    Huynen MA; Neumann AU
    Science; 1996 Jun; 272(5270):1962. PubMed ID: 8658174
    [No Abstract]   [Full Text] [Related]  

  • 39. Estimation of HIV dynamic parameters.
    Wu H; Ding AA; De Gruttola V
    Stat Med; 1998 Nov; 17(21):2463-85. PubMed ID: 9819839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A stochastic modeling of early HIV-1 population dynamics.
    Kamina A; Makuch RW; Zhao H
    Math Biosci; 2001 Apr; 170(2):187-98. PubMed ID: 11292498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.